Half the dosage, similar efficacy, less bleeding: the new tissue plasminogen activator regimen for pulmonary embolism?
Bruce L
BL
Davidson
D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology* / Q000517:prevention & control; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D015994:Incidence; D011655:Pulmonary Embolism / Q000097:blood / Q000188:drug therapy*; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator